
The agency offers its official comment following the UK's historic vote last week to leave the European Union.

The agency offers its official comment following the UK's historic vote last week to leave the European Union.

The UK's EU departure threatens to damage the foundation of several European-wide drug safety and innovation initiatives, and also leaves recent boasts from officials on things like partnership, networking, and transparency just empty words.

Britain's unprecedented vote to leave the European Union will have major ramifications for the biopharma industry, including in areas such as drug regulation, R&D, IP rights, and market access.

The new offering, designed to enhance diabetes trials, combines wearable technology with Quintiles' therapeutic and analytical expertise.




WIRB-Copernicus Group has acquired clinical trials information provider CenterWatch, and added its founder and owner, Kenneth A. Getz, to WCG’s board of directors.


Veeva Systems introduced Veeva Vault CTMS to its suite of clinical applications.

Report shines light on the current state of the Phase II/III clinical trial market and its anticipated direction into 2020.


Medidata and the Southampton Clinical Trials Unit (SCTU) at the University of Southampton have announced a partnership.


Patient recruitment company BBK Worldwide has partnered with Apptomics to develop a new suite of mobile applications for patients, caregivers, physicians and payers.



Commonwealth Informatics announced that it has been contracted by the FDA to provide consulting services and technical assistance.


Oracle announced that Pfizer has selected Oracles Cloud Services across its clinical trial portfolio.


Green Circle Health and Integrated Clinical Solutions announced a partnership to provide a passageway through which patient-reported data can be communicated with a trial sponsor or agent.


IMS Health has acquired Privacy Analytics to extend its real-world evidence capabilities.


Catch up on the latest business and people news in the industry today.


Bioclinica announced the debut of its two new divisions, creating a combined offering focused on patient engagement.

